News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Allison David D.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/24/2023 |
4
| Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Disposed/sold 29,411 options to buy
@ $13.6, valued at
$400k
Disposed/sold 1,038 options to buy
@ $19.55, valued at
$20.3k
Disposed/sold 881 options to buy
@ $20.2, valued at
$17.8k
Disposed/sold 524 options to buy
@ $33.49, valued at
$17.5k
Disposed/sold 1,499 options to buy
@ $11.78, valued at
$17.7k
|
|
| 01/10/2023 |
4
| Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 1,499 options to buy
@ $11.78, valued at
$17.7k
|
|
| 10/12/2022 |
4
| Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 524 options to buy
@ $33.49, valued at
$17.5k
|
|
| 07/20/2022 |
4
| Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 881 options to buy
@ $20.2, valued at
$17.8k
|
|
| 07/20/2022 |
4/A
| Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 1,038 options to buy
@ $19.55, valued at
$20.3k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2022 |
3
| Allison David D. (Director) has filed a Form 3 on CinCor Pharma, Inc. |
| 07/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|